+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Primary Sclerosing Cholangitis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 99 Pages
  • February 2024
  • Region: Global
  • Prof Research
  • ID: 5911102
Description Jump to:

Quick Summary:

In an era of transformative advancements in pharmaceuticals, understanding the competitive landscape of the Primary Sclerosing Cholangitis Drug market is crucial for industry leaders aiming to make informed decisions. Our comprehensive market research report provides a meticulously analyzed overview of this niche segment, encompassing pivotal dynamics that drive the therapeutic area.

Delving into the intricacies of the market across key global regions, this report affords a granular look at the supply and demand chain, strategic regional insights, and the performance of major players that shape the industry landscape. Interpretations of comprehensive data, including SWOT analyses, revenue streams, gross margins, and market shares are tailored specifically for senior business executives seeking a decisive edge in the market.

Designed to enhance strategic planning and propel market positioning, our report offers executives the insights necessary to capitalize on market opportunities with foresight and precision. By encapsulating both historical trends and forward-looking projections, we equip you with the intelligence to navigate the market’s future trajectory.

This report describes the global market size of Primary Sclerosing Cholangitis Drug from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Primary Sclerosing Cholangitis Drug as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Types Segment

  • Immunosuppressants
  • Chelators
  • Steroids
  • Others

Companies Covered

  • Albireo Pharma Inc.
  • Avolynt Inc.
  • Calliditas Therapeutics AB
  • Cascade Pharmaceuticals Inc.
  • Chemomab Therapeutics Ltd.
  • CymaBay Therapeutics Inc.
  • Dr. Falk Pharma GmbH
  • Galmed Pharmaceuticals Ltd.
  • Gannex Pharma Co. Ltd.
  • Genfit Corp.
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Primary Sclerosing Cholangitis Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Primary Sclerosing Cholangitis Drug Market in North America (2019-2029)
8.1 Primary Sclerosing Cholangitis Drug Market Size
8.2 Primary Sclerosing Cholangitis Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Primary Sclerosing Cholangitis Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Primary Sclerosing Cholangitis Drug Market in South America (2019-2029)
9.1 Primary Sclerosing Cholangitis Drug Market Size
9.2 Primary Sclerosing Cholangitis Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Primary Sclerosing Cholangitis Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Primary Sclerosing Cholangitis Drug Market in Asia & Pacific (2019-2029)
10.1 Primary Sclerosing Cholangitis Drug Market Size
10.2 Primary Sclerosing Cholangitis Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Primary Sclerosing Cholangitis Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Primary Sclerosing Cholangitis Drug Market in Europe (2019-2029)
11.1 Primary Sclerosing Cholangitis Drug Market Size
11.2 Primary Sclerosing Cholangitis Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Primary Sclerosing Cholangitis Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Primary Sclerosing Cholangitis Drug Market in MEA (2019-2029)
12.1 Primary Sclerosing Cholangitis Drug Market Size
12.2 Primary Sclerosing Cholangitis Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Primary Sclerosing Cholangitis Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Primary Sclerosing Cholangitis Drug Market (2019-2024)
13.1 Primary Sclerosing Cholangitis Drug Market Size
13.2 Primary Sclerosing Cholangitis Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Primary Sclerosing Cholangitis Drug Market Size by Type
Chapter 14 Global Primary Sclerosing Cholangitis Drug Market Forecast (2024-2029)
14.1 Primary Sclerosing Cholangitis Drug Market Size Forecast
14.2 Primary Sclerosing Cholangitis Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Primary Sclerosing Cholangitis Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Albireo Pharma Inc.
15.1.1 Company Profile
15.1.2 Main Business and Primary Sclerosing Cholangitis Drug Information
15.1.3 SWOT Analysis of Albireo Pharma Inc.
215.1.4 Albireo Pharma Inc. Primary Sclerosing Cholangitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.2 Avolynt Inc.
15.2.1 Company Profile
15.2.2 Main Business and Primary Sclerosing Cholangitis Drug Information
15.2.3 SWOT Analysis of Avolynt Inc.
215.2.4 Avolynt Inc. Primary Sclerosing Cholangitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.3 Calliditas Therapeutics AB
15.3.1 Company Profile
15.3.2 Main Business and Primary Sclerosing Cholangitis Drug Information
15.3.3 SWOT Analysis of Calliditas Therapeutics AB
215.3.4 Calliditas Therapeutics AB Primary Sclerosing Cholangitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.4 Cascade Pharmaceuticals Inc.
15.4.1 Company Profile
15.4.2 Main Business and Primary Sclerosing Cholangitis Drug Information
15.4.3 SWOT Analysis of Cascade Pharmaceuticals Inc.
215.4.4 Cascade Pharmaceuticals Inc. Primary Sclerosing Cholangitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.5 Chemomab Therapeutics Ltd.
15.5.1 Company Profile
15.5.2 Main Business and Primary Sclerosing Cholangitis Drug Information
15.5.3 SWOT Analysis of Chemomab Therapeutics Ltd.
215.5.4 Chemomab Therapeutics Ltd. Primary Sclerosing Cholangitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.6 CymaBay Therapeutics Inc.
15.6.1 Company Profile
15.6.2 Main Business and Primary Sclerosing Cholangitis Drug Information
15.6.3 SWOT Analysis of CymaBay Therapeutics Inc.
215.6.4 CymaBay Therapeutics Inc. Primary Sclerosing Cholangitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.7 Dr. Falk Pharma GmbH
15.7.1 Company Profile
15.7.2 Main Business and Primary Sclerosing Cholangitis Drug Information
15.7.3 SWOT Analysis of Dr. Falk Pharma GmbH
215.7.4 Dr. Falk Pharma GmbH Primary Sclerosing Cholangitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.8 Galmed Pharmaceuticals Ltd.
15.8.1 Company Profile
15.8.2 Main Business and Primary Sclerosing Cholangitis Drug Information
15.8.3 SWOT Analysis of Galmed Pharmaceuticals Ltd.
215.8.4 Galmed Pharmaceuticals Ltd. Primary Sclerosing Cholangitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.9 Gannex Pharma Co. Ltd.
15.9.1 Company Profile
15.9.2 Main Business and Primary Sclerosing Cholangitis Drug Information
15.9.3 SWOT Analysis of Gannex Pharma Co. Ltd.
215.9.4 Gannex Pharma Co. Ltd. Primary Sclerosing Cholangitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.10 Genfit Corp.
15.10.1 Company Profile
15.10.2 Main Business and Primary Sclerosing Cholangitis Drug Information
15.10.3 SWOT Analysis of Genfit Corp.
215.10.4 Genfit Corp. Primary Sclerosing Cholangitis Drug Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Primary Sclerosing Cholangitis Drug Report
Table Data Sources of Primary Sclerosing Cholangitis Drug Report
Table Major Assumptions of Primary Sclerosing Cholangitis Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Primary Sclerosing Cholangitis Drug Picture
Table Primary Sclerosing Cholangitis Drug Classification
Table Primary Sclerosing Cholangitis Drug Applications
Table Drivers of Primary Sclerosing Cholangitis Drug Market
Table Restraints of Primary Sclerosing Cholangitis Drug Market
Table Opportunities of Primary Sclerosing Cholangitis Drug Market
Table Threats of Primary Sclerosing Cholangitis Drug Market
Table COVID-19 Impact For Primary Sclerosing Cholangitis Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Primary Sclerosing Cholangitis Drug
Table Cost Structure Analysis of Primary Sclerosing Cholangitis Drug
Table Key End Users
Table Latest News of Primary Sclerosing Cholangitis Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Primary Sclerosing Cholangitis Drug Market
Table Policy of Primary Sclerosing Cholangitis Drug Market
Table 2019-2029 North America Primary Sclerosing Cholangitis Drug Market Size
Figure 2019-2029 North America Primary Sclerosing Cholangitis Drug Market Size and CAGR
Table 2019-2029 North America Primary Sclerosing Cholangitis Drug Market Size by Application
Table 2019-2024 North America Primary Sclerosing Cholangitis Drug Key Players Revenue
Table 2019-2024 North America Primary Sclerosing Cholangitis Drug Key Players Market Share
Table 2019-2029 North America Primary Sclerosing Cholangitis Drug Market Size by Type
Table 2019-2029 United States Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Canada Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Mexico Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 South America Primary Sclerosing Cholangitis Drug Market Size
Figure 2019-2029 South America Primary Sclerosing Cholangitis Drug Market Size and CAGR
Table 2019-2029 South America Primary Sclerosing Cholangitis Drug Market Size by Application
Table 2019-2024 South America Primary Sclerosing Cholangitis Drug Key Players Revenue
Table 2019-2024 South America Primary Sclerosing Cholangitis Drug Key Players Market Share
Table 2019-2029 South America Primary Sclerosing Cholangitis Drug Market Size by Type
Table 2019-2029 Brazil Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Argentina Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Chile Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Peru Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Asia & Pacific Primary Sclerosing Cholangitis Drug Market Size
Figure 2019-2029 Asia & Pacific Primary Sclerosing Cholangitis Drug Market Size and CAGR
Table 2019-2029 Asia & Pacific Primary Sclerosing Cholangitis Drug Market Size by Application
Table 2019-2024 Asia & Pacific Primary Sclerosing Cholangitis Drug Key Players Revenue
Table 2019-2024 Asia & Pacific Primary Sclerosing Cholangitis Drug Key Players Market Share
Table 2019-2029 Asia & Pacific Primary Sclerosing Cholangitis Drug Market Size by Type
Table 2019-2029 China Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 India Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Japan Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 South Korea Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Southeast Asia Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Australia Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Europe Primary Sclerosing Cholangitis Drug Market Size
Figure 2019-2029 Europe Primary Sclerosing Cholangitis Drug Market Size and CAGR
Table 2019-2029 Europe Primary Sclerosing Cholangitis Drug Market Size by Application
Table 2019-2024 Europe Primary Sclerosing Cholangitis Drug Key Players Revenue
Table 2019-2024 Europe Primary Sclerosing Cholangitis Drug Key Players Market Share
Table 2019-2029 Europe Primary Sclerosing Cholangitis Drug Market Size by Type
Table 2019-2029 Germany Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 France Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 United Kingdom Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Italy Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Spain Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Belgium Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Netherlands Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Austria Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Poland Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Russia Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 MEA Primary Sclerosing Cholangitis Drug Market Size
Figure 2019-2029 MEA Primary Sclerosing Cholangitis Drug Market Size and CAGR
Table 2019-2029 MEA Primary Sclerosing Cholangitis Drug Market Size by Application
Table 2019-2024 MEA Primary Sclerosing Cholangitis Drug Key Players Revenue
Table 2019-2024 MEA Primary Sclerosing Cholangitis Drug Key Players Market Share
Table 2019-2029 MEA Primary Sclerosing Cholangitis Drug Market Size by Type
Table 2019-2029 Egypt Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Israel Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 South Africa Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Gulf Cooperation Council Countries Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2029 Turkey Primary Sclerosing Cholangitis Drug Market Size
Table 2019-2024 Global Primary Sclerosing Cholangitis Drug Market Size by Region
Table 2019-2024 Global Primary Sclerosing Cholangitis Drug Market Size Share by Region
Table 2019-2024 Global Primary Sclerosing Cholangitis Drug Market Size by Application
Table 2019-2024 Global Primary Sclerosing Cholangitis Drug Market Share by Application
Table 2019-2024 Global Primary Sclerosing Cholangitis Drug Key Vendors Revenue
Figure 2019-2024 Global Primary Sclerosing Cholangitis Drug Market Size and Growth Rate
Table 2019-2024 Global Primary Sclerosing Cholangitis Drug Key Vendors Market Share
Table 2019-2024 Global Primary Sclerosing Cholangitis Drug Market Size by Type
Table 2019-2024 Global Primary Sclerosing Cholangitis Drug Market Share by Type
Table 2024-2029 Global Primary Sclerosing Cholangitis Drug Market Size by Region
Table 2024-2029 Global Primary Sclerosing Cholangitis Drug Market Size Share by Region
Table 2024-2029 Global Primary Sclerosing Cholangitis Drug Market Size by Application
Table 2024-2029 Global Primary Sclerosing Cholangitis Drug Market Share by Application
Table 2024-2029 Global Primary Sclerosing Cholangitis Drug Key Vendors Revenue
Figure 2024-2029 Global Primary Sclerosing Cholangitis Drug Market Size and Growth Rate
Table 2024-2029 Global Primary Sclerosing Cholangitis Drug Key Vendors Market Share
Table 2024-2029 Global Primary Sclerosing Cholangitis Drug Market Size by Type
Table 2024-2029 Primary Sclerosing Cholangitis Drug Global Market Share by Type

Companies Mentioned

  • Albireo Pharma Inc.
  • Avolynt Inc.
  • Calliditas Therapeutics AB
  • Cascade Pharmaceuticals Inc.
  • Chemomab Therapeutics Ltd.
  • CymaBay Therapeutics Inc.
  • Dr. Falk Pharma GmbH
  • Galmed Pharmaceuticals Ltd.
  • Gannex Pharma Co. Ltd.
  • Genfit Corp.
  • Gilead Sciences
  • HighTide Therapeutics Inc.
  • Immunic Inc.
  • Invea Therapeutics Inc.
  • LISCure Biosciences Inc.
  • Mirum Pharmaceuticals Inc.
  • Morphic Holding Inc.
  • Pliant Therapeutics Inc.
  • Selecta Biosciences Inc.
  • Sirnaomics Inc.
  • Qing Bile Therapeutics

Methodology

Loading
LOADING...

Related Topics

Related Reports

Primary Sclerosing Cholangitis Market Report and Forecast 2024-2032 - Product Image

Primary Sclerosing Cholangitis Market Report and Forecast 2024-2032

  • Report
  • 180 Pages
  • Global
From
Primary Sclerosing Cholangitis Treatment - Global Strategic Business Report - Product Image

Primary Sclerosing Cholangitis Treatment - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Primary Sclerosing Cholangitis: Competitive Landscape - Product Image

Primary Sclerosing Cholangitis: Competitive Landscape

  • Report
  • 65 Pages
  • Global
From
Primary Sclerosing Cholangitis - Pipeline Insight, 2024 - Product Image

Primary Sclerosing Cholangitis - Pipeline Insight, 2024

  • Clinical Trials
  • 50 Pages
  • Global
From
Primary Sclerosing Cholangitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Primary Sclerosing Cholangitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 137 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.